[21] Foxall, R., Narang, P., Glaysher, B., Hub, E., Teal, E., Coles, M.C., Ashton Key, M., Beers, S.A., and Cragg, M.S. (2020). Developing a 3D B cell lymphoma culture system to model antibody therapy. Front. Immunol. 11, 605231. END...
Sep 18, 2024 - This article defines and reviews the potential of stem cell therapy as a promising treatment option for various medical conditions. It also discusses and defines stem cells and their importance in the field of regenerative medicine.
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study Adam Mainguy Carole Soussain Caroline Houillier ResearchOpen Access19 Nov 2024Bone Marrow Transplantation ...
Anemia is a common disorder in patients with cancer and can be caused by the disease itself or by cancer-related therapy. The cardinal symptom of anemia, fatigue, is the most commonly reported symptom in patients with cancer and has profound effects on patient well-being and quality of life....
Cord blood stem cells have already been effectively used in the treatment of sickle cell, leukemia, non-Hodgkin#x2032;s lymphoma and some other cancers, life threatening anemias and auto-immune diseases. Current challenges with the use of stem cells in clinical practice include the provisions ...
Regenerative medicine is a new and promising mode of therapy for patients who have limited or no other options for the treatment of their illness. Due to their pleotropic therapeutic potential through the inhibition of inflammation or apoptosis, cell rec
Stem Cell Research, in stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. These transplants...
ConsolidationandPreparationApheresisRadiationTherapyPost-treatmentRecoveryOut-patientFollow-upSection3:AppendicesandReferencesWebsiteReferencesforLymphomaandStemcellTransplantsHospitalDepartmentofOncology,StaffandContactInformationFrequentlyAskedQuestions(FAQ)Section1LymphomaLymphomaisacancerthatarisesfromatypeofwhitebloodcell...
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD Myelosuppression, graft-versus-host disease (GVHD), and relapse remain major causes of morbidity after stem cell transplantation for relapsed lymphoma. In ... ...
Malignant disorders (including myelodysplastic syndromes, acute lymphocytic or myelogenous leukemia,chronic myelogenous leukemia, lymphoma,multiple myeloma,neuroblastoma, and selectedsolid tumorsincluding breast, ovarian, and testicular cancers) • Nonmalignant hematologic disorders (such asaplastic anemia,sickle ...